Cue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
August 03 2022 - 8:00AM
Business Wire
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, announced today that its management team will participate
at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1
Conference on Tuesday, August 16, 2022.
About Cue Health Cue is a healthcare technology company
that makes it easy for individuals to access health information and
places diagnostic information at the center of care. Cue enables
people to manage their health through real-time, actionable, and
connected health information, offering individuals and their
healthcare providers easy access to lab-quality diagnostics
anywhere, anytime, in a device that fits in the palm of the hand.
Cue’s first-of-its-kind COVID-19 test was the first FDA-authorized
molecular diagnostic test for at-home and over-the-counter use
without a prescription and physician supervision. Outside the
United States, Cue has received the CE mark in the European Union,
Interim Order authorization from Health Canada, regulatory approval
from India's Central Drugs Standard Control Organization, and PSAR
authorization from Singapore's Health Sciences Authority. Cue was
founded in 2010 and is headquartered in San Diego. For more
information, please visit www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220803005096/en/
Lorna Williams ir@cuehealth.com
Cue Health press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jul 2023 to Jul 2024